2018 American Transplant Congress
Development and Validation of FLF-Transplant Score to Predict Mortality of Status 1A Candidates
Orthotopic liver transplantation (OLT) is the definitive treatment for patients with fulminant liver failure (Status 1A). We aimed to develop a prognostic model for prediction…2018 American Transplant Congress
Donation after Circulatory Death Donor Liver Transplantation without Ischemic Cholangiopathy: Is It Time to Expand DCD Liver Donor Pool?
Background: To prevent ischemic cholangiopathy (IC) after liver transplantation (LT), a protocol optimizing peri-operative conditions along with thrombolytic (tissue plasminogen activator) donor flush during DCD…2018 American Transplant Congress
Impact of Ambulatory Transplant Pharmacy Services on Outcomes and Readmissions in Adult Abdominal Transplant Recipients
1Northeastern University, Boston, MA; 2Beth Israel Deaconess Medical Center, Boston, MA.
Over the past two decades, the role of transplant pharmacists (Txp Rx) has expanded following revised guidance from UNOS and CMS. There is little data…2018 American Transplant Congress
Lactate/platelet Ratio after Liver Transplantation; a Novel Predictor for Short-Term Graft Failure
Background; Recently, platelet count and lactate level after liver transplantation (LT) have been both separately reported as predictors of graft failure. In this study, we…2018 American Transplant Congress
Impact of Donation after Cardiac Death Allografts on Outcome Following Liver Transplantation for Fulminant Hepatic Failure: An Analysis of the UNOS Database
Scarcity of donor organs in liver transplantation (LT) has necessitated consideration of extended criteria donors (ECDs), including donation after cardiac death (DCD) donors. The narrow…2018 American Transplant Congress
Outcomes of Moderately Macrosteatotic Liver Allografts
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Objectives: Liver transplantation remains the only effective long-term treatment option for patients with end-stage liver disease (ESLD). Organs available for ESLD patients are scarce and…2018 American Transplant Congress
Prediction of Hepatocellular Carcinoma Recurrence Following Liver Transplantation Using Combined Differential Gene Expression, Copy Number Variation and Somatic Mutation Analysis
Liver allocation for transplant candidates with hepatocellular carcinoma is limited by OPTN policy to patients whose tumors remain within size limits defined by Milan criteria.…2018 American Transplant Congress
Sustained Improvement in Patient Reported Outcomes 10 Years after Liver Transplantation by Protocol Longitudinal Assessment of Health Related Quality of Life
Purpose: Data on patient (pt) reported outcomes, especially beyond the first year after liver transplantation (LT) are scarce. We examined changes in health related quality…2018 American Transplant Congress
Ethnic and Age Disparities in Outcomes among Liver Transplant Waitlist Candidates
1University of Alabama at Birmingham, Birmingham; 2Department of Veterans Affairs, Washington DC.
Background: Despite the increasing prevalence of end-stage liver disease (ESLD) in older adults, there is no consensus to determine suitability for liver transplantation (LT) in…2018 American Transplant Congress
Impact of Early Corticosteroid Treatment in Patients with Indeterminate Acute Severe Hepatitis
Background and Aims: Discrimination of acute severe autoimmune hepatitis AIH and drug induced liver injury in patients with indeterminate acute severe Hepatitis is challenging. Early…
- « Previous Page
- 1
- …
- 106
- 107
- 108
- 109
- 110
- …
- 180
- Next Page »